Home/Filings/4/0001140361-15-004581
4//SEC Filing

VASCULAR SOLUTIONS INC 4

Accession 0001140361-15-004581

CIK 0001030206operating

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 4:24 PM ET

Size

16.4 KB

Accession

0001140361-15-004581

Insider Transaction Report

Form 4
Period: 2015-02-05
Transactions
  • Exercise/Conversion

    Common Stock

    2015-02-05$7.88/sh+10,000$78,80028,006 total
  • Sale

    Common Stock

    2015-02-05$27.36/sh10,000$273,60018,006 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2015-02-0510,0000 total
    Exercise: $7.88Exp: 2016-04-18Common Stock (10,000 underlying)
Holdings
  • Common Stock

    18,006
  • Stock Option (Right to Buy)

    Exercise: $9.41Exp: 2017-04-24Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $6.36Exp: 2018-04-22Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $6.39Exp: 2019-04-21Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $9.61Exp: 2020-04-22Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $11.72Exp: 2021-04-22Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $11.63Exp: 2022-05-04Common Stock (10,000 underlying)
    10,000
Footnotes (2)
  • [F1]The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $27.25 to $27.65 per share. Dr. Saucedo has provided to the Company and, upon request, will provide any security holder of the Company or the SEC staff information regarding the number of shares sold at each price within that range.
  • [F2]100% fully vested.

Documents

1 file

Issuer

VASCULAR SOLUTIONS INC

CIK 0001030206

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0001030206

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:24 PM ET
Size
16.4 KB